Visual outcome measures in clinical trials of remyelinating drugs

Overview of attention for article published in BMJ Neurology Open, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 3 X posts from 1 X users, with an upper bound of 15,073 followers.

RT @JNNP_BMJ: This review is a nice summary of visual outcome measures in clinical trials of remyelinating drugs https://t.co/yGjckpVeH2 h…

This review is a nice summary of visual outcome measures in clinical trials of remyelinating drugs https://t.co/yGjckpVeH2 https://t.co/cIk4ZiU0XU

This review is a nice summary of visual outcome measures in clinical trials of remyelinating drugs https://t.co/yGjckpVeH2 https://t.co/bS26EN1myD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.